GNH USA

Europe — EMA

Innovair Nexthaler

GNH USA supplies Innovair Nexthaler (Formoterol fumarate dihydrate / Beclometasone dipropionate), a LABA/ICS for asthma and COPD. Request a quote for supply.

Formoterol Fumarate Dihydrate, Beclometasone Dipropionate Anhydrous

Request sourcing

1
Pack/s

What is Formoterol Fumarate Dihydrate, Beclometasone Dipropionate Anhydrous?

Formoterol fumarate dihydrate and beclometasone dipropionate anhydrous, the active ingredients in Innovair Nexthaler, are a LABA/ICS combination presented as a dry powder inhaler for inhalation use. It provides maintenance therapy for asthma and chronic obstructive pulmonary disease (COPD) in adults and adolescents.

GNH USA supplies Innovair Nexthaler as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide across multiple regions.

What is Formoterol Fumarate Dihydrate, Beclometasone Dipropionate Anhydrous used for?

Innovair Nexthaler combines a long‑acting β2‑agonist and an inhaled corticosteroid to control airway inflammation and bronchoconstriction.

Asthma: improves symptom control and reduces the frequency of exacerbations COPD: enhances lung function and decreases the risk of flare‑ups

What are the side effects of Formoterol Fumarate Dihydrate, Beclometasone Dipropionate Anhydrous?

The inhaled combination may cause a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Throat irritation or soreness - Cough - Hoarseness or voice change - Oral candidiasis (thrush)

Serious or Rare Side Effects: - Paradoxical bronchospasm - Severe allergic reaction (anaphylaxis) - Pneumonia

What precautions apply to Formoterol Fumarate Dihydrate, Beclometasone Dipropionate Anhydrous?

Before initiating therapy, consider the following precautions. - Inhaler technique: ensure correct use to maximize drug delivery - Oral hygiene: rinse mouth after each dose to reduce risk of thrush - Cardiovascular status: monitor heart rate and blood pressure, especially in patients with arrhythmias - Dose titration: use the lowest effective dose to control symptoms - Pregnancy and lactation: assess risk‑benefit before prescribing - Store at ambient temperature: keep in original container, protect from moisture and heat

What does Formoterol Fumarate Dihydrate, Beclometasone Dipropionate Anhydrous interact with?

Review potential drug interactions prior to prescribing.

Major Interactions (Avoid): - Beta‑blockers: may diminish bronchodilator effect and precipitate bronchospasm - Potent CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): can increase systemic corticosteroid exposure

Moderate Interactions (Monitor Closely): - Diuretics: may enhance hypokalemia risk when combined with β2‑agonist - Theophylline: additive stimulant effect on heart rate - Anticholinergic bronchodilators: may cause excessive bronchodilation

Frequently asked questions

What is Innovair Nexthaler used for?+
Innovair Nexthaler is a fixed‑dose inhalation product that combines a long‑acting β2‑agonist with an inhaled corticosteroid. It is prescribed as a maintenance therapy to control symptoms and reduce exacerbations in patients with asthma or chronic obstructive pulmonary disease (COPD).
How does formoterol work in Innovair Nexthaler?+
Formoterol is a long‑acting β2‑adrenergic agonist. It binds to β2 receptors on airway smooth muscle, stimulating adenylate cyclase and increasing cyclic AMP. The rise in cyclic AMP leads to relaxation of the smooth muscle, producing sustained bronchodilation that helps keep the airways open.
What is the usual dose of Innovair Nexthaler?+
The prescribed dose of Innovair Nexthaler is individualized by the treating physician based on the patient’s severity of disease, age, and response to therapy. The prescriber determines the number of inhalations per day and any dose adjustments required for optimal control.
Is Innovair Nexthaler safe during pregnancy or breastfeeding?+
Safety data for Innovair Nexthaler in pregnancy and lactation are limited. Clinicians should weigh the potential benefits against possible risks and consider alternative treatments when appropriate. If therapy is deemed necessary, it should be used at the lowest effective dose and under close medical supervision.
How do I order Innovair Nexthaler from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. The sales team then replies with pricing, availability, shipping details and any required import documentation.
How does Innovair Nexthaler compare with other LABA/ICS inhalers?+
Innovair Nexthaler delivers its active ingredients via a dry‑powder Nexthaler device, which provides breath‑actuated dosing without the need for propellants. Compared with metered‑dose inhalers, the dry‑powder system may offer more consistent dose delivery and reduced coordination requirements, while the pharmacologic profile of formoterol and beclometasone is similar to other LABA/ICS combinations.
What are the storage requirements for Innovair Nexthaler?+
Innovair Nexthaler should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the device away from moisture, direct sunlight and excessive heat to maintain dose integrity and device functionality.
How is Innovair Nexthaler administered?+
The patient inhales the medication through the Nexthaler device by taking a steady, deep breath through the mouthpiece. No propellant is required; the inhaler releases a measured dose of dry powder when the patient’s inspiratory flow reaches the required threshold. After each use, the mouthpiece should be closed to protect the dose.
What are the most serious risks associated with Innovair Nexthaler?+
Serious risks include paradoxical bronchospasm, which can worsen breathing, and severe allergic reactions such as anaphylaxis. In rare cases, prolonged high‑dose use may lead to adrenal suppression. Patients should be educated to seek immediate medical attention if they experience sudden breathlessness, swelling, rash, or other signs of a severe reaction.
Who should not use Innovair Nexthaler?+
Innovair Nexthaler is contraindicated in individuals with a known hypersensitivity to formoterol, beclometasone, or any excipients in the formulation. It should also be avoided in patients who have experienced a severe allergic reaction to other inhaled corticosteroids or long‑acting β2‑agonists.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Formoterol Fumarate Dihydrate, Beclometasone Dipropionate Anhydrous
Route
Inhalation Use
Manufacturer
Chiesi Farmaceutici S.P.A.
Origin
EU

Related products

Alabaster

Alabaster

Formoterol Fumarate Dihydrate, Beclometasone Dipropionate Anhydrous

Master Pharma S.R.L.
EU
Combair

Combair

Formoterol Fumarate Dihydrate, Beclometasone Dipropionate Anhydrous

Chiesi Pharmaceuticals Gmbh
EU
Combair Nexthaler

Combair Nexthaler

Formoterol Fumarate Dihydrate, Beclometasone Dipropionate Anhydrous

Chiesi Pharmaceuticals Gmbh
EU
Formodual

Formodual

Formoterol Fumarate Dihydrate, Beclometasone Dipropionate Anhydrous

Chiesi Pharmaceuticals Gmbh
EU